UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-16751 ELEVANCE HEALTH, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Elevance Health (ELV) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Elevance Health is a member of the Medical sector. This group includes 1069 individual stocks and currently holds a Zacks Sector Rank of #6. The Zacks Sector Rank considers 1 ...

INDIANAPOLIS--(BUSINESS WIRE)--Today JUST Capital along with CNBC released its annual JUST 100 list as part of its 2024 Rankings of America’s Most JUST Companies. Elevance Health (NYSE: ELV) ranked #8 overall and was recognized for the 6th consecutive year for its commitment to serving its workers, customers, communities, the environment, and shareholders. The JUST 100 are determined by scoring performance across a full range social impact and sustainability criteria and comparing companies head-to-head. ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Elevance Health (ELV) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Elevance Health is a member of our Medical group, which includes 1073 different companies and currentl ...

mediaphotosElevance Health, Inc. (NYSE:ELV) reported earnings on January 24th with a favorable reception. Elevance Health is the largest commercial insurance company in the United States. Its comprehensive business model centers on 'whole health'. Elevance Health's services extend across various domains of healthcare. These include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies. Their competitive advantage comes from both their scale ...

A pharmacist serves a customer. Cecilie_Arcurs/E+ via Getty Images Sizable dividend hikes can be telling about a company's overall tone toward its future and how much a company values its shareholders. All else equal, big dividend boosts convey a sense of optimism on the part of management and a commitment to rewarding shareholders. Elevance Health (NYSE:ELV) is a recent example of a company that I believe is trending in the right direction. The managed care giant just upped its quarterly dividend per share ...

Elevance Health, Inc. (ELV) reported fourth-quarter 2023 adjusted earnings of $5.62 per share, which surpassed the Zacks Consensus Estimate by 1.3%. The bottom line climbed 15.2% year over year.Operating revenues rose 7% year over year to almost $42.5 billion in the quarter under review. Also, the top line beat the consensus mark by 1.5%.The strong quarterly results benefited on the back of improved premiums in the Commercial Health Benefits business and better performance in the Carelon Services business. ...

Elevance Health, Inc. (NYSE:ELV) Q4 2023 Earnings Conference Call January 24, 2024 8:30 AM ET Company Participants Steve Tanal - VP of IR Gail Boudreaux - President and CEO Mark Kaye - CFO Peter Haytaian - President of Carelon Felicia Norwood - President, Government Health Benefits Business. Morgan Kendrick - President, Commercial Health Benefits Business Conference Call Participants A.J. Rice - UBS Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Sarah James - Cancer Fitzgerald Stephen Baxt ...

4Q 2023 Earnings Presentation • 2018 – 2023 adjusted diluted EPS CAGR of 16% exceeded the high end of our long-term target growth rate • Enhance the whole health of our members by serving as their lifetime, trusted health partner, especially through maximizing continuity of coverage for those subject to Medicaid redeterminations and adding key • We will continue to invest in high-growth opportunities to build upon our foundation for sustained, longterm growth • 4Q 2023 adjusted diluted EPS of $5.62 grew 15. ...

Elevance Health (ELV) came out with quarterly earnings of $5.62 per share, beating the Zacks Consensus Estimate of $5.55 per share. This compares to earnings of $5.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.26%. A quarter ago, it was expected that this health insurer would post earnings of $8.45 per share when it actually produced earnings of $8.99, delivering a surprise of 6.39%.Over the last four quarters, the comp ...